Abnormal fasting, post-load or combined glucose values on oral glucose tolerance test and pregnancy outcomes in women with gestational diabetes mellitus
Introduction
Gestational diabetes mellitus (GDM) develops during pregnancy in women whose pancreatic function is insufficient to overcome the insulin resistance associated with the pregnant state [1]. According to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, the diagnosis of GDM is established when elevated plasma glucose is detected during a 75 g 2-hour oral glucose tolerance test (OGTT) between the 24th and 28th weeks of gestation [2]. According to the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study, approximately half of women diagnosed with GDM had abnormal fasting blood glucose, while the rest had abnormal post-prandial blood glucose values [3]. Previous studies have reported that abnormal fasting blood glucose is associated with increased need for insulin therapy in GDM complicated pregnancies [4], [5], [6], [7]. Aim of this study is to investigate, the differences between GDM complicated pregnancies with abnormal fasting, post-load or combined blood glucose values on OGTT, regarding outcomes of the pregnancy.
Section snippets
Study design
We followed prospectively a cohort of pregnant women with singleton pregnancy and gestational diabetes mellitus (GDM), who attended our prenatal clinic.
Setting
Our study is a part of a large prospective study from 2010 to 2018, undertaken in the Second Department of obstetrics and Gynaecology, National and Kapodistrian University of Athens, Areteion Hospital in collaboration with a private medical setting of antenatal care Embryocare, Fetal Medicine Unit, Athens, Greece. All participating women signed
Results
From the initial cohort of 10.638 pregnancies, 6818 met the inclusion criteria, of which 831 (11.5%) were complicated by GDM. 180 (21.7%) of the GDM complicated pregnancies had abnormal fasting only blood glucose at OGTT, 402 (48.4%) had abnormal post-load only blood glucose and 249 (30%) had combined fasting and post-load abnormal blood glucose values. Figure 1 displays the selection process of the included cohort.
Main findings
We compared pregnancy outcomes of women with GDM and abnormal fasting blood glucose at OGTT (T0) to those with abnormal post-load (T-post) and combined abnormal blood glucose (T-comb). The percentage of large for gestational age neonates and the mean birth weight centile were greater in the group of women with abnormal fasting blood glucose (T0). The need for insulin treatment was greater in the combined abnormal blood glucose (T-comb). Abnormal fasting blood glucose was the only independent
Conclusion
Women with GDM and abnormal fasting blood glucose are at increased risk for large for gestational age neonates, while women with GDM and combined fasting and post-load abnormal blood glucose are at increased risk for insulin therapy. These women require closer monitoring in order to avoid adverse pregnancy outcomes and further research is needed in order to identify the various pathophysiologic mechanisms that lead to this phenotype.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
None.
Funding
The present study received no funding.
References (23)
Dietary therapy for gestational diabetes: how long is long enough?
Obstet Gynecol [Internet].
(1999 Jun)- et al.
Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?
Diabetes Res Clin Pract.
(2008) - et al.
The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus
Am J Obstet Gynecol.
(2010) - et al.
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
Metabolism
(1989) - et al.
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Clin Biochem.
(2009) - Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus. Chicago, Illinois, USA....
- et al.
International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Diabetes Care
(2010) - et al.
Cooperative Research Group for the HSCR. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
Diabetes Care
(2012) - et al.
Gestational diabetes mellitus: Who requires insulin therapy?
Aust New Zeal J Obstet Gynaecol.
(2011) - et al.
A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus
Diabetologia
(2016)
A position statement of the American Diabetes Association
Diabetes Care
Cited by (0)
- 1
Both authors contributed equally to this manuscript.